Operative Surgical Procedures Breast Carcinoma | Sentinel Lymph Node Biopsy | Axillary lymph nodes Dissection Full | Axillary lymph nodes Quantity Involvement Positive
Item
patients must have undergone surgical treatment for breast cancer with adequate evaluation of lymph node status with a sentinel lymph node procedure or full axillary dissection, with positive involvement of 1-3 axillary lymph nodes as confirmed by histologic examination.
boolean
C0543467 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C0796693 (UMLS CUI [2])
C0729594 (UMLS CUI [3,1])
C0012737 (UMLS CUI [3,2])
C0443225 (UMLS CUI [3,3])
C0729594 (UMLS CUI [4,1])
C1265611 (UMLS CUI [4,2])
C1314939 (UMLS CUI [4,3])
C1514241 (UMLS CUI [4,4])
ECOG performance status
Item
ecog performance status 0 or 1
boolean
C1520224 (UMLS CUI [1])
Cancer treatment | Systemic Chemotherapy In addition to Hormone Therapy
Item
patient must be a candidate for treatment of their cancer with systemic chemotherapy in addition to hormonal therapy
boolean
C0920425 (UMLS CUI [1])
C1883256 (UMLS CUI [2,1])
C0332287 (UMLS CUI [2,2])
C0279025 (UMLS CUI [2,3])
TNM Breast tumor staging
Item
eligible staging criteria: t1-3 n1 m0
boolean
C0474926 (UMLS CUI [1])
Breast Carcinoma Central Pathology Review | Breast Carcinoma Adequate Oncotype DX Breast Cancer Assay
Item
breast tumor must undergo central pathology review at ghi and must be found adequate for the oncotype dx assay.
boolean
C0678222 (UMLS CUI [1,1])
C2347585 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2,1])
C0205411 (UMLS CUI [2,2])
C1709318 (UMLS CUI [2,3])
Breast Carcinoma Estrogen receptor positive Immunohistochemistry | Breast Carcinoma HER2 Positive Immunohistochemistry | Breast Carcinoma Estrogen receptor positive FISH | Breast Carcinoma HER2 Positive FISH
Item
breast tumor must be estrogen-receptor positive and her2 positive (ihc/fish) as per institutional guidelines
boolean
C0678222 (UMLS CUI [1,1])
C0279754 (UMLS CUI [1,2])
C0021044 (UMLS CUI [1,3])
C0678222 (UMLS CUI [2,1])
C2348909 (UMLS CUI [2,2])
C0021044 (UMLS CUI [2,3])
C0678222 (UMLS CUI [3,1])
C0279754 (UMLS CUI [3,2])
C0162789 (UMLS CUI [3,3])
C0678222 (UMLS CUI [4,1])
C2348909 (UMLS CUI [4,2])
C0162789 (UMLS CUI [4,3])
Medical History Breast Carcinoma Breast Same
Item
patient has a prior history of breast cancer in the same breast
boolean
C0262926 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C0006141 (UMLS CUI [1,3])
C0445247 (UMLS CUI [1,4])
Breast Carcinoma Operable Quantity
Item
patient as been newly diagnosed with more than one operable primary breast tumor
boolean
C0678222 (UMLS CUI [1,1])
C0205188 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Multicentric Breast Carcinoma
Item
patient has multi-centric tumors (note: patients with multi-focal tumors may be included)
boolean
C2986664 (UMLS CUI [1])
Secondary malignant neoplasm of female breast
Item
patient has known metastatic breast cancer
boolean
C0346993 (UMLS CUI [1])
Invasive Carcinoma Size
Item
patient has <2mm invasive tumor as assessed by local pathologist
boolean
C1334274 (UMLS CUI [1,1])
C0456389 (UMLS CUI [1,2])
Neoadjuvant Therapy Kind Any
Item
patient has received any kind of neoadjuvant treatment
boolean
C0600558 (UMLS CUI [1,1])
C0332307 (UMLS CUI [1,2])
C1552551 (UMLS CUI [1,3])
Patient Inappropriate Adjuvant Chemotherapy
Item
presence of clinical factors rendering the patient a non-viable candidate for adjuvant chemotherapy
boolean
C0030705 (UMLS CUI [1,1])
C1548788 (UMLS CUI [1,2])
C0085533 (UMLS CUI [1,3])
Medical condition Interferes with Informed Consent | Medical condition Interferes with Study Subject Participation Status
Item
presence of a current medical condition that would interfere with patient's ability to consent and participate in this study
boolean
C3843040 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,3])
C3843040 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C2348568 (UMLS CUI [2,3])